Autopsy report · NCT03101501

A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.

“The manufacturing company of the Raindrop Corneal Inlay has stopped distribution or sales of the product.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 1 year before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Key-Whitman Eye Center

Sponsor type

University, hospital or other

Conditions

Presbyopia

Interventions

Mitomycin c; Raindrop Near Vision Inlay

Participants

9

Sites

3

Countries

United States

Trials that died the same way

• A Study Raindrop Near Vision Inlay in Presbyopes Implanted in Corneal Pockets
  “Corneal Inlay supplier no longer in business” (74% match in meaning)
• The Study for Evaluate of Satety and Dfficacy of Hemostatic Device
  “The company stopped manufacturing the product” (55% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.